Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Allergan Plc (AGN)

Allergan Plc (AGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 63,503,972
  • Shares Outstanding, K 329,002
  • Annual Sales, $ 16,089 M
  • Annual Income, $ -5,271 M
  • 60-Month Beta 1.20
  • Price/Sales 3.95
  • Price/Cash Flow 5.26
  • Price/Book 1.09
Trade AGN with:
  • Price/Earnings ttm 10.94
  • Earnings Per Share ttm 17.64
  • Most Recent Earnings 5.22 on 02/10/20
  • Next Earnings Date 05/07/20
  • Annual Dividend & Yield 2.96 (0.00%)
  • Most Recent Dividend 0.740 on 04/15/20
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 4.24
  • Number of Estimates 1
  • High Estimate 4.24
  • Low Estimate 4.24
  • Prior Year 3.79
  • Growth Rate Est. (year over year) +11.87%

Price Performance

See More
Period Period Low Period High Performance
1-Month
181.21 +6.52%
on 04/09/20
196.45 -1.75%
on 05/06/20
+11.94 (+6.59%)
since 04/08/20
3-Month
158.67 +21.65%
on 03/18/20
202.21 -4.55%
on 02/12/20
-4.03 (-2.05%)
since 02/07/20
52-Week
114.27 +68.92%
on 06/17/19
202.21 -4.55%
on 02/12/20
+52.97 (+37.82%)
since 05/08/19

Most Recent Stories

More News
Connect Biopharma Strengthens Leadership Team with Key Hire

and TAICANG, SUZHOU, , /PRNewswire/ -- , a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies...

AGN : 193.02 (+0.02%)
LLY : 208.55 (-1.96%)
Frazier Healthcare Partners Adds Highly Experienced Investor to Life Sciences Team

Frazier Healthcare Partners announced the planned addition of Albert Cha, M.D., Ph.D. as Managing Partner on the Life Sciences team. He has over 20 years of experience investing in public and private biopharmaceutical...

AGN : 193.02 (+0.02%)
ASND : 150.27 (-3.50%)
KALV : 16.00 (-2.14%)
ACRS : 16.49 (-5.66%)
BHVN : 85.13 (-4.11%)
MNLO : 1.3500 (-2.17%)
SRRA : 15.67 (-0.95%)
BIOD : 0.65 (+6.56%)
Anophthalmia And Microphthalmia Market Size Is Projected to grow at a 5.8% CAGR By 2023

AERI : 18.21 (-0.22%)
AGN : 193.02 (+0.02%)
BAYRY : 15.8500 (+0.76%)
NVS : 94.37 (-1.64%)
PFE : 36.76 (-1.47%)
REGN : 527.73 (-3.01%)
SNPHF : 16.5500 (+3.44%)
VRX.TO : 30.80 (-3.33%)
Cataract Surgery Devices Market - Global Industry Analysis, Size, Share, Trends, Growth and Forecast 2021 2026

AGN : 193.02 (+0.02%)
CZMWF : 133.2000 (-0.22%)
NVS : 94.37 (-1.64%)
VRX.TO : 30.80 (-3.33%)
US Glaucoma Drugs Market Size 2021 By Trends Evaluation, Business Opportunities, Consumption, Growth Rate, Top Manufacturer, New Project Investment, Regional Analysis and Forecast to 2027

AI Market Report is working on a new report title Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027? Rise in prevalence of eye disorders such as Presbyopia, Macular Degeneration...

AGN : 193.02 (+0.02%)
ITEK : 3.04 (-5.00%)
MRK : 79.42 (-1.03%)
NMUS : 0.6500 (-9.52%)
NVS : 94.37 (-1.64%)
OCAT : 8.47 (+0.12%)
OCUL : 17.73 (-3.80%)
OHRP : 5.39 (+30.19%)
PRGO : 44.20 (-0.65%)
PFE : 36.76 (-1.47%)
SNPHF : 16.5500 (+3.44%)
SCMP : 18.05 (+0.28%)
TEVA : 12.13 (-1.54%)
VRX.TO : 30.80 (-3.33%)
Insights on the Biosimilar Global Market to 2026 - Featuring Allergan, Biocon and BioXpress Therapeutics Among Others

The "Biosimilar Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's offering.

AGN : 193.02 (+0.02%)
Aesthetic Devices Market 2021 Systematic Review and full research report

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Allergan...

MMM : 179.27 (+1.89%)
AGN : 193.02 (+0.02%)
CYNO : 66.15 (+0.23%)
NSRGY : 116.6700 (+1.20%)
SIEN : 4.70 (-3.29%)
ELOS : 11.00 (unch)
VRX.TO : 30.80 (-3.33%)
ZLTQ : 56.48 (unch)
ZBH : 153.77 (-2.81%)
Global Alzheimer's Disease Diagnostics and Therapeutics Market Report 2020-2025 - Cholinesterase Inhibitors are Expected to Hold the Highest Market Share

, /PRNewswire/ -- The report has been added to offering.

AGN : 193.02 (+0.02%)
ESALF : 67.0000 (unch)
MRK : 79.42 (-1.03%)
PFE : 36.76 (-1.47%)
Anophthalmia And Microphthalmia Market Regional Insights, Growth Outlook, Business Overview, Share Value and Size Estimation By 2023

AERI : 18.21 (-0.22%)
AGN : 193.02 (+0.02%)
BAYRY : 15.8500 (+0.76%)
NVS : 94.37 (-1.64%)
PFE : 36.76 (-1.47%)
REGN : 527.73 (-3.01%)
SNPHF : 16.5500 (+3.44%)
VRX.TO : 30.80 (-3.33%)
Allergan Aesthetics and Allergan, an AbbVie Company, to Present 16 Neurotoxin Research Abstracts Across Multiple Therapeutic and Cosmetic Indications at the TOXINS 2021 Virtual Conference

, Jan. 15, 2021 /PRNewswire/ -- Allergan Aesthetics and Allergan, an AbbVie company (NYSE: ABBV), announced today that scientific and clinical experts in the field of neurotoxins will present results...

AGN : 193.02 (+0.02%)
ABBV : 105.66 (-2.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 194.42
1st Resistance Point 193.72
Last Price 193.02
1st Support Level 191.98
2nd Support Level 190.94
3rd Support Level N/A

See More

52-Week High 202.21
Last Price 193.02
Fibonacci 61.8% 168.62
Fibonacci 50% 158.24
Fibonacci 38.2% 147.86
52-Week Low 114.27

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar